Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
44
COO Quote, Financials, Valuation and Earnings
Last price:
$73.27
Seasonality move
:
13.29%
Day range:
$72.05 - $73.34
52-week range:
$65.00 - $112.38
Dividend yield:
0%
P/E ratio:
35.56x
P/S ratio:
3.69x
P/B ratio:
1.76x
Volume:
2.6M
Avg. volume:
3M
1-year change:
-19.46%
Market cap:
$14.6B
Revenue:
$3.9B
EPS (TTM):
$2.06
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
COO
The Cooper Companies
|
$995.2M | $0.93 | 6.1% | 105.39% | $92.09 |
|
BSX
Boston Scientific
|
$4.9B | $0.73 | 18.78% | 229.3% | $117.36 |
|
KIDS
OrthoPediatrics
|
$61.4M | -$0.28 | 16.28% | -7.69% | $36.71 |
|
LUCY
Innovative Eyewear
|
$1M | -$0.77 | 223.96% | -58.82% | $7.00 |
|
NXGL
NexGel
|
$3.1M | -$0.07 | 113.89% | -50% | $6.00 |
|
STAA
Staar Surgical
|
$40.9M | -$0.56 | -58.72% | -760% | $19.20 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
COO
The Cooper Companies
|
$73.26 | $92.09 | $14.6B | 35.56x | $0.01 | 0% | 3.69x |
|
BSX
Boston Scientific
|
$104.65 | $117.36 | $154.8B | 76.39x | $0.00 | 0% | 8.88x |
|
KIDS
OrthoPediatrics
|
$22.65 | $36.71 | $561M | -- | $0.00 | 0% | 2.47x |
|
LUCY
Innovative Eyewear
|
$2.13 | $7.00 | $8.2M | -- | $0.00 | 0% | 2.40x |
|
NXGL
NexGel
|
$2.39 | $6.00 | $18.3M | -- | $0.00 | 0% | 1.62x |
|
STAA
Staar Surgical
|
$17.27 | $19.20 | $855.3M | 49.73x | $0.00 | 0% | 3.06x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
COO
The Cooper Companies
|
23.76% | 0.582 | 15.85% | 0.89x |
|
BSX
Boston Scientific
|
33.49% | 0.780 | 7.48% | 0.68x |
|
KIDS
OrthoPediatrics
|
17.41% | 0.247 | 11.97% | 2.74x |
|
LUCY
Innovative Eyewear
|
-- | 4.943 | -- | 11.96x |
|
NXGL
NexGel
|
11.28% | -0.559 | 2.86% | 0.84x |
|
STAA
Staar Surgical
|
-- | 0.847 | -- | 3.88x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
COO
The Cooper Companies
|
$679.1M | $184.8M | 3.89% | 5.15% | 16.83% | $18.1M |
|
BSX
Boston Scientific
|
$3.2B | $937M | 6.35% | 9.57% | 19.02% | $277M |
|
KIDS
OrthoPediatrics
|
$38.3M | -$10.9M | -9.9% | -11.21% | -17.82% | -$8.4M |
|
LUCY
Innovative Eyewear
|
$220.5K | -$1.9M | -97.69% | -97.69% | -418.88% | -$2.4M |
|
NXGL
NexGel
|
$1.2M | -$777K | -51.9% | -59.55% | -23.41% | -$400K |
|
STAA
Staar Surgical
|
$28M | -$34.7M | -17.97% | -17.97% | -81.56% | -$7.2M |
The Cooper Companies vs. Competitors
-
Which has Higher Returns COO or BSX?
Boston Scientific has a net margin of 8.75% compared to The Cooper Companies's net margin of 14.45%. The Cooper Companies's return on equity of 5.15% beat Boston Scientific's return on equity of 9.57%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Companies67.75% $0.44 $10.9B BSXBoston Scientific68.84% $0.45 $33.6B -
What do Analysts Say About COO or BSX?
The Cooper Companies has a consensus price target of $92.09, signalling upside risk potential of 25.7%. On the other hand Boston Scientific has an analysts' consensus of $117.36 which suggests that it could grow by 12.15%. Given that The Cooper Companies has higher upside potential than Boston Scientific, analysts believe The Cooper Companies is more attractive than Boston Scientific.
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Companies8 7 0 BSXBoston Scientific23 2 0 -
Is COO or BSX More Risky?
The Cooper Companies has a beta of 0.985, which suggesting that the stock is 1.451% less volatile than S&P 500. In comparison Boston Scientific has a beta of 0.679, suggesting its less volatile than the S&P 500 by 32.134%.
-
Which is a Better Dividend Stock COO or BSX?
The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. Boston Scientific pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or BSX?
The Cooper Companies quarterly revenues are $1B, which are smaller than Boston Scientific quarterly revenues of $4.7B. The Cooper Companies's net income of $87.7M is lower than Boston Scientific's net income of $674M. Notably, The Cooper Companies's price-to-earnings ratio is 35.56x while Boston Scientific's PE ratio is 76.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 3.69x versus 8.88x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Companies3.69x 35.56x $1B $87.7M BSXBoston Scientific8.88x 76.39x $4.7B $674M
-
Which has Higher Returns COO or KIDS?
OrthoPediatrics has a net margin of 8.75% compared to The Cooper Companies's net margin of -20.34%. The Cooper Companies's return on equity of 5.15% beat OrthoPediatrics's return on equity of -11.21%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Companies67.75% $0.44 $10.9B KIDSOrthoPediatrics73% -$0.46 $420.3M -
What do Analysts Say About COO or KIDS?
The Cooper Companies has a consensus price target of $92.09, signalling upside risk potential of 25.7%. On the other hand OrthoPediatrics has an analysts' consensus of $36.71 which suggests that it could grow by 62.09%. Given that OrthoPediatrics has higher upside potential than The Cooper Companies, analysts believe OrthoPediatrics is more attractive than The Cooper Companies.
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Companies8 7 0 KIDSOrthoPediatrics3 1 0 -
Is COO or KIDS More Risky?
The Cooper Companies has a beta of 0.985, which suggesting that the stock is 1.451% less volatile than S&P 500. In comparison OrthoPediatrics has a beta of 1.098, suggesting its more volatile than the S&P 500 by 9.802%.
-
Which is a Better Dividend Stock COO or KIDS?
The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. OrthoPediatrics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. OrthoPediatrics pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or KIDS?
The Cooper Companies quarterly revenues are $1B, which are larger than OrthoPediatrics quarterly revenues of $52.4M. The Cooper Companies's net income of $87.7M is higher than OrthoPediatrics's net income of -$10.7M. Notably, The Cooper Companies's price-to-earnings ratio is 35.56x while OrthoPediatrics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 3.69x versus 2.47x for OrthoPediatrics. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Companies3.69x 35.56x $1B $87.7M KIDSOrthoPediatrics2.47x -- $52.4M -$10.7M
-
Which has Higher Returns COO or LUCY?
Innovative Eyewear has a net margin of 8.75% compared to The Cooper Companies's net margin of -391.35%. The Cooper Companies's return on equity of 5.15% beat Innovative Eyewear's return on equity of -97.69%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Companies67.75% $0.44 $10.9B LUCYInnovative Eyewear48.52% -$0.72 $7.5M -
What do Analysts Say About COO or LUCY?
The Cooper Companies has a consensus price target of $92.09, signalling upside risk potential of 25.7%. On the other hand Innovative Eyewear has an analysts' consensus of $7.00 which suggests that it could grow by 228.64%. Given that Innovative Eyewear has higher upside potential than The Cooper Companies, analysts believe Innovative Eyewear is more attractive than The Cooper Companies.
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Companies8 7 0 LUCYInnovative Eyewear0 0 0 -
Is COO or LUCY More Risky?
The Cooper Companies has a beta of 0.985, which suggesting that the stock is 1.451% less volatile than S&P 500. In comparison Innovative Eyewear has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock COO or LUCY?
The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Innovative Eyewear offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. Innovative Eyewear pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or LUCY?
The Cooper Companies quarterly revenues are $1B, which are larger than Innovative Eyewear quarterly revenues of $454.5K. The Cooper Companies's net income of $87.7M is higher than Innovative Eyewear's net income of -$1.8M. Notably, The Cooper Companies's price-to-earnings ratio is 35.56x while Innovative Eyewear's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 3.69x versus 2.40x for Innovative Eyewear. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Companies3.69x 35.56x $1B $87.7M LUCYInnovative Eyewear2.40x -- $454.5K -$1.8M
-
Which has Higher Returns COO or NXGL?
NexGel has a net margin of 8.75% compared to The Cooper Companies's net margin of -25.37%. The Cooper Companies's return on equity of 5.15% beat NexGel's return on equity of -59.55%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Companies67.75% $0.44 $10.9B NXGLNexGel42.34% -$0.09 $6.2M -
What do Analysts Say About COO or NXGL?
The Cooper Companies has a consensus price target of $92.09, signalling upside risk potential of 25.7%. On the other hand NexGel has an analysts' consensus of $6.00 which suggests that it could grow by 151.05%. Given that NexGel has higher upside potential than The Cooper Companies, analysts believe NexGel is more attractive than The Cooper Companies.
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Companies8 7 0 NXGLNexGel0 0 0 -
Is COO or NXGL More Risky?
The Cooper Companies has a beta of 0.985, which suggesting that the stock is 1.451% less volatile than S&P 500. In comparison NexGel has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock COO or NXGL?
The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. NexGel offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. NexGel pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or NXGL?
The Cooper Companies quarterly revenues are $1B, which are larger than NexGel quarterly revenues of $2.8M. The Cooper Companies's net income of $87.7M is higher than NexGel's net income of -$712K. Notably, The Cooper Companies's price-to-earnings ratio is 35.56x while NexGel's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 3.69x versus 1.62x for NexGel. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Companies3.69x 35.56x $1B $87.7M NXGLNexGel1.62x -- $2.8M -$712K
-
Which has Higher Returns COO or STAA?
Staar Surgical has a net margin of 8.75% compared to The Cooper Companies's net margin of -127.29%. The Cooper Companies's return on equity of 5.15% beat Staar Surgical's return on equity of -17.97%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Companies67.75% $0.44 $10.9B STAAStaar Surgical65.76% -$1.10 $350M -
What do Analysts Say About COO or STAA?
The Cooper Companies has a consensus price target of $92.09, signalling upside risk potential of 25.7%. On the other hand Staar Surgical has an analysts' consensus of $19.20 which suggests that it could grow by 11.18%. Given that The Cooper Companies has higher upside potential than Staar Surgical, analysts believe The Cooper Companies is more attractive than Staar Surgical.
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Companies8 7 0 STAAStaar Surgical3 9 1 -
Is COO or STAA More Risky?
The Cooper Companies has a beta of 0.985, which suggesting that the stock is 1.451% less volatile than S&P 500. In comparison Staar Surgical has a beta of 0.582, suggesting its less volatile than the S&P 500 by 41.753%.
-
Which is a Better Dividend Stock COO or STAA?
The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Staar Surgical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. Staar Surgical pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or STAA?
The Cooper Companies quarterly revenues are $1B, which are larger than Staar Surgical quarterly revenues of $42.6M. The Cooper Companies's net income of $87.7M is higher than Staar Surgical's net income of -$54.2M. Notably, The Cooper Companies's price-to-earnings ratio is 35.56x while Staar Surgical's PE ratio is 49.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 3.69x versus 3.06x for Staar Surgical. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Companies3.69x 35.56x $1B $87.7M STAAStaar Surgical3.06x 49.73x $42.6M -$54.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
